Your browser doesn't support javascript.
loading
Treatment of steroid-resistant acute graft-vs-host disease after allogeneic marrow transplantation with anti-interleukin-2 receptor antibody (BT563).
Hertenstein, B; Stefanic, M; Sandherr, M; Bunjes, D; Mertens, T; Arnold, R.
Affiliation
  • Hertenstein B; Department of Internal Medicine III (Hematology and Oncology), University of Ulm, Germany.
Transplant Proc ; 26(6): 3114-6, 1994 Dec.
Article in En | MEDLINE | ID: mdl-7998086
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Interleukin-2 / Bone Marrow Transplantation / Immunosuppression Therapy / Graft vs Host Disease / Antibodies, Monoclonal Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Transplant Proc Year: 1994 Document type: Article Affiliation country: Germany Country of publication: United States
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Interleukin-2 / Bone Marrow Transplantation / Immunosuppression Therapy / Graft vs Host Disease / Antibodies, Monoclonal Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Transplant Proc Year: 1994 Document type: Article Affiliation country: Germany Country of publication: United States